No Picture
Los Angeles Biotech News

Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX? (neratinib) in South Korea

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology and Bixink Therapeutics have signed a license agreement in which Bixink will commercialize Puma’s drug NERLYNX in South Korea. […]

No Picture
Los Angeles Biotech News

Two Bit Circus Foundation Announces First Virtual Cardboard Challenge

LOS ANGELES–(BUSINESS WIRE)– #STEAM–Two Bit Circus Foundation, a nonprofit educational organization, today announced plans for the first virtual Cardboard Challenge, an online version of the original event started by Imagination.org, designed to enc… […]

No Picture
Los Angeles Biotech News

Kelly Martin skips to a new CEO suite as his last biotech team raises the white flag

A few months after stepping away from the helm of a biotech with a fluttering pulse, ex-Elan chief Kelly Martin is back in charge of another drug company with its own set of issues to deal with.
Radius Health in Waltham, MA announced that the 61-year-o… […]

No Picture
Los Angeles Biotech News

NKMax America To Present Data from its Natural Killer Cell Immunotherapy Clinical Program at the ASCO20 Virtual Scientific Program

SANTA ANA, Calif., April 30, 2020 (GLOBE NEWSWIRE) — NKMax America, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, today disclosed its three abstract titles rel… […]

No Picture
Los Angeles Biotech News

NantKwest and ImmunityBio to Present at the Bank of America Merrill Lynch Global Healthcare Conference

EL SEGUNDO, Calif.–(BUSINESS WIRE)–NantKwest, Inc. (NASDAQ: NK) and ImmunityBio, Inc., today announced that Patrick Soon-Shiong, M.D., Chairman and CEO of both companies, will present at the virtual Bank of America Merrill Lynch Global Healthcare Con… […]